NEW YORK (GenomeWeb News) – Cancer Genetics said after the close of the market on Wednesday that revenues in its third quarter rose 42 percent year over year.

The cancer diagnostics firm reported revenues of $1.7 million for the three months ended Sept. 30, compared to $1.2 million in the year-ago period. Test volume in the recently completed quarter rose 71 percent year over year to 2,920 from 1,704.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: locus linked to non-syndromic hearing loss, phylogenetic relationships of Klebsiella pneumoniae isolates, and more.

In a column at Nature, researcher Fyodor Kondrashov worries about the influence of politics on Russian science.

The term 'epigenetics' is being used by quacks to give them a veneer of science, writes Adam Rutherford at the Observer.

The NIH has issued a preliminary guidance for newborn dried blood spot research.